Gyre Therapeutics
GYRE
#5734
Rank
NZ$1.43 B
Marketcap
$15.31
Share price
-0.76%
Change (1 day)
-43.37%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.18

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.37. In 2023 the company made an earnings per share (EPS) of -$2.37 a decrease over its 2022 EPS that were of $0.007318.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.18-107.43%
2023-$2.37-32451.8%
2022$0.007318-90.93%
2021$0.08064